Nirrin Technologies founder and CEO Bryan Hassell discusses how simplifying protein quantitation could improve method transferability, support automation, and reduce bottlenecks across biologics development and manufacturing.
Bryan Hassell
Advertisement
Bryan Hassell is ceo and founder of Nirrin Technologies.
Articles by Bryan Hassell
Advertisement
Latest Updated Articles
Advertisement
Advertisement